Skip to content

Marcus Rosenhagen-Lapoirie

1 paper in the library · publishing 2022

Papers

Sort Most recent Most cited

Utilisation de la kétamine en psychiatrie : mise à jour

Revue Médicale Suisse 2022 Marie-Thérèse Clerc, Marcus Rosenhagen-Lapoirie, Armin Von Gunten

Ketamine has demonstrated at a lower dose a robust and rapid antidepressant effect due to a mechanism of action different from conventional treatments. It is now included in several international recommendations on treatment-resistant depression. Ketamine may be used in both out- or in-patient settings, generally by way of intravenous or intranasal formulations provided the fulfillment of...